ImageneBio, Inc. (IMA)
NASDAQ: IMA · Real-Time Price · USD
5.75
-0.08 (-1.37%)
At close: Apr 28, 2026, 4:00 PM EDT
5.64
-0.11 (-1.91%)
After-hours: Apr 28, 2026, 5:37 PM EDT
ImageneBio Revenue
In the year 2025, ImageneBio had annual revenue of $800.00K, down -77.14%.
Revenue (ttm)
$800.00K
Revenue Growth
-77.14%
P/S Ratio
80.39
Revenue / Employee
$53,333
Employees
15
Market Cap
64.31M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 800.00K | -2.70M | -77.14% |
| Dec 31, 2024 | 3.50M | -5.66M | -61.79% |
| Dec 31, 2023 | 9.16M | -6.46M | -41.35% |
| Dec 31, 2022 | 15.62M | -15.37M | -49.59% |
| Dec 31, 2021 | 30.99M | 21.79M | 237.01% |
| Dec 31, 2020 | 9.19M | -4.56M | -33.15% |
| Dec 31, 2019 | 13.75M | 12.76M | 1,289.19% |
| Dec 31, 2018 | 990.00K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Cue Biopharma | 27.47M |
| MindWalk Holdings | 20.70M |
| BeyondSpring | 1.88M |
| MediciNova | 409.66K |
| iBio, Inc. | 300.00K |
| Impact BioMedical | 32.00K |
IMA News
- 15 days ago - ImageneBio $30 Million Private Placement Ignites Stock - Benzinga
- 15 days ago - ImageneBio Announces $30 Million Private Placement - GlobeNewsWire
- 6 weeks ago - ImageneBio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 7 weeks ago - ImageneBio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Company Update - GlobeNewsWire
- 2 months ago - ImageneBio to Participate in Leerink Global Healthcare Conference - GlobeNewsWire
- 2 months ago - ImageneBio Appoints Immunology Drug Development Veteran Dr. Ben Porter-Brown as Chief Medical Officer - GlobeNewsWire
- 5 months ago - ImageneBio Reports Third Quarter 2025 Financial Results and Provides IMG-007 Program Update Following Closing of Reverse Merger, Concurrent Financing, and Strengthening of Management Team - GlobeNewsWire
- 6 months ago - ImageneBio to Participate in Fourth Quarter 2025 Investor Conferences - GlobeNewsWire